Skip to content

Clinical Efficacy and Mechanisms of Five-Tone Imagery Hypnosis Technique (Yu Mode) for Insomnia of Heart–Kidney Disharmony Pattern: A Study Based on the Kidney–Will Theory of "Fear Injures the Kidney"

Clinical Efficacy and Mechanisms of Five-Tone Imagery Hypnosis Technique (Yu Mode) for Insomnia of Heart–Kidney Disharmony Pattern: A Study Based on the Kidney–Will Theory of "Fear Injures the Kidney"

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124247
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-05-12
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Trial Group:CBT-I (Cognitive Behavioral Therapy) + Five-Note Imagery Hypnosis Technique (Hospital Intervention: Lying position listening to Yu-tone music 'Purifying Water', Chinese herbal aroma, image
Home Intervention: Listening to Yu-tone music 'Purifying Water' before sleep, imagery guidance), 5 times per week for 4 consecutive weeks
Control Group:CBT-I (Cognitive Behavioral Therapy, including sleep hygiene education, stimulus control therapy, sleep restriction therapy, relaxation training, cognitive therapy), once per week, 30-60

Sponsors

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the above diagnostic criteria of both traditional Chinese medicine and Western medicine; 2. Be aged between 40 and 70 years, inclusive; 3. Have not received any traditional Chinese medicine or Western medicine treatment for insomnia within the past month; 4. Have a total Pittsburgh Sleep Quality Index (PSQI) score >= 7, and an Insomnia Severity Index (ISI) score between 8 and 21, indicating mild to moderate insomnia; 5. Possess the ability to read, write, and communicate, and be able to cooperate with the physician; 6. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe or decompensated systemic diseases, such as heart, liver, or kidney diseases; 2. Individuals with long-term alcohol use, drug dependence, or mental disorders; 3. Pregnant or lactating women; 4. Individuals who have received insomnia-related treatment within 30 days before screening, including sedative-hypnotic medications, CBT-I, or other traditional Chinese medicine characteristic interventions for insomnia; 5. Individuals with nasal trauma or diseases that affect olfactory function; 6. Individuals with deafness or hearing impairment that affects auditory function; 7. Individuals with obvious cognitive impairment, or those who are unable to understand the study content or cooperate with CBT-I intervention, scale assessments, and follow-up.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);

Secondary

MeasureTime frame
Memorial University of Newfoundland Scale of Happiness (MUNSH);Insomnia Severity Index (ISI);Fear of Progression Questionnaire-Short Form (FoP-Q-SF);Security Questionnaire (SQ);TCM Syndrome Score;Heart rate variablity;

Countries

China

Contacts

Public ContactZhou Xia

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine

1311049436@qq.com+86 180 5347 1828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026